Greenland Mines Ltd.
- GRML
- NASDAQ
- Other Precious Metals
- Neurodegenerative Disease Therapeutics
- Cell and Gene Therapy
$6.00
Today −13.79%Quote Oct 16, 2026, 08:00 PM UTC
+101.34%over the last month
Max drawdown −65.3%From 1-month high −59.7%3 months −35.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$953.1M
Quote Oct 16
Next earnings
—
Data unavailable
Latest analyst target
—
Data unavailable
Floor
$3.85
35.8% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about GRMLPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Other Precious Metals
Employees
5